Rimiterol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Rimiterol
Rimiterol.svg
Rimiterol ball-and-stick model.png
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.046.627 Edit this at Wikidata
Chemical and physical data
FormulaC12H17NO3
Molar mass223.268 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Rimiterol (INN/USAN) is a third-generation[1] short-acting[2][3] β2 agonist.

See also[edit]

References[edit]

  1. ^ Palma-Carlos, A. G.; Palma-Carlos, G. S. (1986). "Beta-2-agonists of Third Generation". Allergie et Immunologie. 18 (4): 31–32, 35. PMID 2899434.
  2. ^ Lai, CK; Twentyman, OP; Holgate, ST (October 1989). "The Effect of an Increase in Inhaled Allergen Dose After Rimiterol Hydrobromide on the Occurrence and Magnitude of the Late Asthmatic Response and the Associated Change in Nonspecific Bronchial Responsiveness". The American Review of Respiratory Disease. 140 (4): 917–23. doi:10.1164/ajrccm/140.4.917. PMID 2572192.
  3. ^ Ydreborg, SO; Svedmyr, N; Thiringer, G (April 1977). "Comparison of Rimiterol and Terbutaline, Given by Aerosol, in a Long-term Study". Scandinavian Journal of Respiratory Diseases. 58 (2): 117–24. PMID 16339.